摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-Phenyl-piperazinomethyl)-cyclohexanon-(2) | 735-78-4

中文名称
——
中文别名
——
英文名称
1-(4-Phenyl-piperazinomethyl)-cyclohexanon-(2)
英文别名
N-Phenyl-N'-(2-oxo-cyclohexylmethyl)-piperazin;2-(4-phenyl-piperazin-1-ylmethyl)-cyclohexanone;2-(4-Phenyl-1-piperazinylmethyl)cyclohexanone;2-[(4-phenylpiperazin-1-yl)methyl]cyclohexan-1-one
1-(4-Phenyl-piperazinomethyl)-cyclohexanon-(2)化学式
CAS
735-78-4
化学式
C17H24N2O
mdl
——
分子量
272.39
InChiKey
XNMJONWYRULMSK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    419.6±30.0 °C(Predicted)
  • 密度:
    1.092±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    23.6
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:5aa3d2a27f0e55ac23a6a76b6ad023f2
查看

反应信息

  • 作为反应物:
    描述:
    1-(4-Phenyl-piperazinomethyl)-cyclohexanon-(2)盐酸羟胺sodium acetate 作用下, 以 甲醇 为溶剂, 生成 (E)-2-((4-phenylpiperazin-1-yl)methyl)cyclohexan-1-one oxime 、 N-Phenyl-N'-(2-oximino-cyclohexylmethyl)-piperazin
    参考文献:
    名称:
    Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists
    摘要:
    Hit-to-lead optimization of a HTS hit led to new carbamoyloxime derivatives. After identification of an advanced hit (8d) the CYP enzyme inhibitory activity of this class of compounds was successfully eliminated. Systematic exploration of different parts of the advanced hit led us to some promising lead compounds with mGluR5 affinities comparable to that of MPEP. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.06.075
  • 作为产物:
    描述:
    参考文献:
    名称:
    Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists
    摘要:
    Hit-to-lead optimization of a HTS hit led to new carbamoyloxime derivatives. After identification of an advanced hit (8d) the CYP enzyme inhibitory activity of this class of compounds was successfully eliminated. Systematic exploration of different parts of the advanced hit led us to some promising lead compounds with mGluR5 affinities comparable to that of MPEP. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.06.075
点击查看最新优质反应信息

文献信息

  • Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists
    作者:János Galambos、Gábor Wágner、Katalin Nógrádi、Attila Bielik、László Molnár、Amrita Bobok、Attila Horváth、Béla Kiss、Sándor Kolok、József Nagy、Dalma Kurkó、Mónika L. Bakk、Mónika Vastag、Katalin Sághy、István Gyertyán、Krisztina Gál、István Greiner、Zsolt Szombathelyi、György M. Keserű、György Domány
    DOI:10.1016/j.bmcl.2010.06.075
    日期:2010.8
    Hit-to-lead optimization of a HTS hit led to new carbamoyloxime derivatives. After identification of an advanced hit (8d) the CYP enzyme inhibitory activity of this class of compounds was successfully eliminated. Systematic exploration of different parts of the advanced hit led us to some promising lead compounds with mGluR5 affinities comparable to that of MPEP. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多